Nicholas R - Search Results

1

Nicholas R, Chataway J. Nicholas R, et al. BMJ Clin Evid. 2007 Aug 15;2007:1202. BMJ Clin Evid. 2007. PMID: 19454107 Review.

2

Multiple sclerosis.

Ford H, Nicholas R. Ford H, et al. Among authors: nicholas r. Clin Evid. 2005 Dec;(14):1637-51. Clin Evid. 2005. PMID: 16620466 Review. No abstract available.

3

Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis.

Papadopoulos D, Dukes S, Patel R, Nicholas R, Vora A, Reynolds R. Papadopoulos D, et al. Among authors: nicholas r. Brain Pathol. 2009 Apr;19(2):238-53. doi: 10.1111/j.1750-3639.2008.00177.x. Epub 2008 May 20. Brain Pathol. 2009. PMID: 18492094 Free PMC article.

4

Anticholinergics for urinary symptoms in multiple sclerosis.

Nicholas RS, Friede T, Hollis S, Young CA. Nicholas RS, et al. Cochrane Database Syst Rev. 2009 Jan 21;(1):CD004193. doi: 10.1002/14651858.CD004193.pub2. Cochrane Database Syst Rev. 2009. Update in: Cochrane Database Syst Rev. 2015 Jun 05;(6):CD004193. doi: 10.1002/14651858.CD004193.pub3 PMID: 19160231 Updated. Review.

5

Evidence for abnormal tau phosphorylation in early aggressive multiple sclerosis.

Anderson JM, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MG, Chandran S. Anderson JM, et al. Among authors: nicholas r. Acta Neuropathol. 2009 May;117(5):583-9. doi: 10.1007/s00401-009-0515-2. Epub 2009 Mar 14. Acta Neuropathol. 2009. PMID: 19288121

6

Abnormal tau phosphorylation in primary progressive multiple sclerosis.

Anderson JM, Patani R, Reynolds R, Nicholas R, Compston A, Spillantini MG, Chandran S. Anderson JM, et al. Among authors: nicholas r. Acta Neuropathol. 2010 May;119(5):591-600. doi: 10.1007/s00401-010-0671-4. Epub 2010 Mar 21. Acta Neuropathol. 2010. PMID: 20306268

7

Bladder symptoms in multiple sclerosis: a review of pathophysiology and management.

Nicholas R, Young C, Friede T. Nicholas R, et al. Expert Opin Drug Saf. 2010 Nov;9(6):905-15. doi: 10.1517/14740338.2010.501793. Expert Opin Drug Saf. 2010. PMID: 20569078 Review.

8

A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.

Chataway J, Nicholas R, Todd S, Miller DH, Parsons N, Valdés-Márquez E, Stallard N, Friede T. Chataway J, et al. Among authors: nicholas r. Mult Scler. 2011 Jan;17(1):81-8. doi: 10.1177/1352458510382129. Epub 2010 Aug 26. Mult Scler. 2011. PMID: 20798135

9

A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.

Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, Aloisi F, Reynolds R. Magliozzi R, et al. Among authors: nicholas r. Ann Neurol. 2010 Oct;68(4):477-93. doi: 10.1002/ana.22230. Ann Neurol. 2010. PMID: 20976767

10

Designing a seamless phase II/III clinical trial using early outcomes for treatment selection: an application in multiple sclerosis.

Friede T, Parsons N, Stallard N, Todd S, Valdes Marquez E, Chataway J, Nicholas R. Friede T, et al. Among authors: nicholas r. Stat Med. 2011 Jun 15;30(13):1528-40. doi: 10.1002/sim.4202. Epub 2011 Feb 22. Stat Med. 2011. PMID: 21341301

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

831 results

Search Page

Filters